Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1PCAS Ecully FR
02 1MENADIONA, S.L. Palafolls ES
01 2Clomifene citrate
01 1France
02 1Spain
01 1Suspended by EDQM GMP non-compliance
02 1Valid
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
Certificate Number : R1-CEP 2003-251 - Rev 06
Status : Valid
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Certificate Number : R1-CEP 2003-193 - Rev 04
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2020-08-07
Type : Chemical
Substance Number : 997
33
PharmaCompass offers a list of Clomiphene Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clomiphene Citrate manufacturer or Clomiphene Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clomiphene Citrate manufacturer or Clomiphene Citrate supplier.
PharmaCompass also assists you with knowing the Clomiphene Citrate API Price utilized in the formulation of products. Clomiphene Citrate API Price is not always fixed or binding as the Clomiphene Citrate Price is obtained through a variety of data sources. The Clomiphene Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Repros Therapeutic Brand of Enclomiphene Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Repros Therapeutic Brand of Enclomiphene Citrate, including repackagers and relabelers. The FDA regulates Repros Therapeutic Brand of Enclomiphene Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Repros Therapeutic Brand of Enclomiphene Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Repros Therapeutic Brand of Enclomiphene Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Repros Therapeutic Brand of Enclomiphene Citrate supplier is an individual or a company that provides Repros Therapeutic Brand of Enclomiphene Citrate active pharmaceutical ingredient (API) or Repros Therapeutic Brand of Enclomiphene Citrate finished formulations upon request. The Repros Therapeutic Brand of Enclomiphene Citrate suppliers may include Repros Therapeutic Brand of Enclomiphene Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Repros Therapeutic Brand of Enclomiphene Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Repros Therapeutic Brand of Enclomiphene Citrate CEP of the European Pharmacopoeia monograph is often referred to as a Repros Therapeutic Brand of Enclomiphene Citrate Certificate of Suitability (COS). The purpose of a Repros Therapeutic Brand of Enclomiphene Citrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Repros Therapeutic Brand of Enclomiphene Citrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Repros Therapeutic Brand of Enclomiphene Citrate to their clients by showing that a Repros Therapeutic Brand of Enclomiphene Citrate CEP has been issued for it. The manufacturer submits a Repros Therapeutic Brand of Enclomiphene Citrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Repros Therapeutic Brand of Enclomiphene Citrate CEP holder for the record. Additionally, the data presented in the Repros Therapeutic Brand of Enclomiphene Citrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Repros Therapeutic Brand of Enclomiphene Citrate DMF.
A Repros Therapeutic Brand of Enclomiphene Citrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Repros Therapeutic Brand of Enclomiphene Citrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Repros Therapeutic Brand of Enclomiphene Citrate suppliers with CEP (COS) on PharmaCompass.
